These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2382906)

  • 1. Pulmonary veno-occlusive disease and its response to vasodilator agents.
    Palevsky HI; Pietra GG; Fishman AP
    Am Rev Respir Dis; 1990 Aug; 142(2):426-9. PubMed ID: 2382906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil.
    Creagh-Brown BC; Nicholson AG; Showkathali R; Gibbs JS; Howard LS
    Thorax; 2008 Oct; 63(10):933-4. PubMed ID: 18820120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
    Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
    Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary venous occlusive disease. Case report and literature review].
    Bütikofer J; Vogt P; Knoblauch M
    Schweiz Med Wochenschr; 1991 Aug; 121(33):1169-75. PubMed ID: 1925445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics and survival of patients with pulmonary veno-occlusive disease].
    Jiang X; Chen FD; He J; Jiang R; Di RM; Zhao QH; Jing ZC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):896-900. PubMed ID: 22321271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good response to pulmonary arterial hypertension-targeted therapy in 2 pulmonary veno-occlusive disease patients: A case report.
    Zhang L; Wang Y; Zhang R
    Medicine (Baltimore); 2021 Oct; 100(41):e27334. PubMed ID: 34731104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.
    Sourla E; Paspala A; Boutou A; Kontou P; Stanopoulos I; Pitsiou G
    Ther Adv Respir Dis; 2013 Apr; 7(2):119-23. PubMed ID: 23235992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.
    Montani D; Jaïs X; Price LC; Achouh L; Degano B; Mercier O; Mussot S; Fadel E; Dartevelle P; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2009 Dec; 34(6):1348-56. PubMed ID: 19541723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease.
    Sato H; Sugimura K; Miura M; Konno R; Kozu K; Yaoita N; Shimizu T; Yamamoto S; Aoki T; Tatebe S; Satoh K; Shimokawa H
    Tohoku J Exp Med; 2019 Feb; 247(2):69-73. PubMed ID: 30700638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary veno-occlusive disease: a case report and a review of therapeutic possibilities.
    De Vries TW; Weening JJ; Roorda RJ
    Eur Respir J; 1991 Sep; 4(8):1029-32. PubMed ID: 1783079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary veno-occlusive disease: a case series and new observations.
    Holcomb BW; Loyd JE; Ely EW; Johnson J; Robbins IM
    Chest; 2000 Dec; 118(6):1671-9. PubMed ID: 11115457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives.
    Barboza CE; Jardim CV; Hovnanian AL; Dias BA; Souza R
    J Bras Pneumol; 2008 Sep; 34(9):749-52. PubMed ID: 18982212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary veno-occlusive disease: an uncommon cause of pulmonary hypertension.
    Masters K; Bennett S
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23378546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in pulmonary veno-occlusive disease: time for a rethink?
    Luo Q; Jin Q; Zhao Z; Zhao Q; Yu X; Yan L; Zhang Y; Xiong C; Liu Z
    BMC Pulm Med; 2019 Dec; 19(1):257. PubMed ID: 31856792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary veno-occlusive disease. Fatal progression of pulmonary hypertension despite steroid-induced remission of interstitial pneumonitis.
    Gilroy RJ; Teague MW; Loyd JE
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1130-3. PubMed ID: 2024825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 24-year-old male patient with pulmonary veno-occlusive disease - case report].
    Cwiek E; Przemęcka M; Marczak J; Kuś J; Langfort R; Górski P
    Pneumonol Alergol Pol; 2014; 82(3):271-5. PubMed ID: 24793152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease.
    Okumura H; Nagaya N; Kyotani S; Sakamaki F; Nakanishi N; Fukuhara S; Yutani C
    Chest; 2002 Sep; 122(3):1096-8. PubMed ID: 12226062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences.
    Montani D; Kemp K; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
    Semin Respir Crit Care Med; 2009 Aug; 30(4):411-20. PubMed ID: 19634080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II.
    Runo JR; Vnencak-Jones CL; Prince M; Loyd JE; Wheeler L; Robbins IM; Lane KB; Newman JH; Johnson J; Nichols WC; Phillips JA
    Am J Respir Crit Care Med; 2003 Mar; 167(6):889-94. PubMed ID: 12446270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary veno-occlusive disease: recent progress and current challenges.
    Montani D; O'Callaghan DS; Savale L; Jaïs X; Yaïci A; Maitre S; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
    Respir Med; 2010 Jul; 104 Suppl 1():S23-32. PubMed ID: 20456932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.